George B. Abercrombie, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 10,000 shares at $11.04 ($110K) on 2022-04-18, disclosed to the SEC on 2022-04-20.
Open-market sale of $110k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.04 | 5,000 | $55K | 50.0% |
| 2 | $11.04 | 5,000 | $55K | 50.0% |
| Total | $11.04 avg | 10,000 | $110K | 100% |
| Filing → |
| BCRX | SELL | 2021-09-17 | $75K | — | Filing → |
| BCRX | SELL | 2021-09-14 | $1.1M | — | Filing → |
| BCRX | SELL | 2021-07-19 | $78K | — | Filing → |